Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prolaio’s platform has been validated with five FDA-cleared algorithms, over four million hours of patient data analyzed, 20+ issued patents, and operations in more than 26 countries. The system enables high-density real-world data collection from devices and EHRs to optimize clinical trial design for cardiovascular drugs, improve patient monitoring outside the hospital setting, reduce admissions/readmissions through predictive analytics, and support individualized care plans. It is used by biopharma partners to accelerate therapy development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Prolaio.